Company Overview and News

 
BRIEF-Crystal Peak Minerals Announces Issuance Of Shares

2018-03-09 reuters
* CRYSTAL PEAK MINERALS INC. ANNOUNCES ISSUANCE OF SHARES AS INTEREST PAYMENT PURSUANT TO CONVERTIBLE LOAN AGREEMENT WITH EMR

 
BRIEF-Crystal Peak Minerals Announces Appointment Of New CEO

2018-01-03 reuters
* CRYSTAL PEAK MINERALS INC - APPOINTED JOHN MANSANTI AS PRESIDENT AND CHIEF EXECUTIVE OFFICER OF COMPANY EFFECTIVE JANUARY 2ND

1
Crystal Peak Minerals Inc. Announces the Appointment of New Chief Executive Officer

2018-01-03 marketwired
TORONTO, ONTARIO--(Marketwired - Jan. 3, 2018) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) announced that it has appointed John Mansanti as President and Chief Executive Officer ("CEO") of the Company effective January 2nd. Mr. Mansanti will replace Lance D'Ambrosio who has stepped down as President and Chief Executive Officer and as director. Mr. D'Ambrosio served as Crystal Peak's President and Chief Executive Officer since the Company's listing on the TSX Venture Exchange in 2011.

 
Crystal Peak Minerals Inc. Announces Grant of Stock Options

2017-12-21 marketwired
TORONTO, ONTARIO--(Marketwired - Dec. 21, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) announced today that it has granted an aggregate of 3,700,000 restricted share units ("RSUs") pursuant to its Restricted Share Unit Plan ("Plan") to an officer and director. The RSUs will vest into common shares of the Company in three equal annual installments on January 15, 2018, January 15, 2019, and January 15, 2020.

 
Crystal Peak Minerals Inc. Announces Grant of Stock Options

2017-11-14 marketwired
TORONTO, ONTARIO--(Marketwired - Nov. 14, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) announced today that it has granted options to purchase common shares of the Company ("Options") to certain directors, consultants, and employees; and has issued Restricted Stock Units (RSUs) to certain directors. Crystal Peak granted an aggregate of 750,000 options to certain directors of the Company; an aggregate of 450,000 options to consultants of Crystal Peak or of the Company's subsidiary; and an aggregate of 650,000 options to employees of the Company's subsidiary; and an aggregate of 4,081,609 RSUs to certain directors.

 
Gran Colombia Gold Announces Changes to Its Board of Directors

2017-08-17 marketwired
TORONTO, ON--(Marketwired - August 17, 2017) - Gran Colombia Gold Corp. (TSX: GCM) announced today that it has made changes to its Board of Directors. Effective August 16, 2017, Ian Mann has resigned from the Board of Directors for personal reasons and the Company has appointed De Lyle Bloomquist to fill the position of Rodney Lamond, who resigned earlier in the year. The Company intends to appoint an additional director to fill the vacancy of Ian Mann in due course.

 
Crystal Peak Minerals Inc. Announces Appointment of Chairman

2017-07-06 marketwired
TORONTO, ONTARIO--(Marketwired - July 6, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) is pleased to announce that Herbert E. "Bud" Scruggs, who was elected to the Board of Directors of the Company ("Board") at the last Annual and General Meeting of Shareholders, has been appointed as the non-executive chairman of the Board. In this role, he will help oversee the Company's Sevier Playa Sulphate of Potash Project in southwestern Utah.

 
Crystal Peak Announces Completion of US$12 Million Convertible Loan With EMR

2017-06-29 marketwired
TORONTO, ONTARIO--(Marketwired - June 29, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) is pleased to announce that, further to its news release dated June 22, 2017, it has completed the US$12,000,000 financing (the "Loan") with EMR Capital Investment (No. 5B) Pte. Ltd., an affiliate of EMR Capital Resources Fund 1, LP, its largest shareholder.

 
Crystal Peak Announces Convertible Loan Agreement with EMR

2017-06-22 marketwired
TORONTO, ONTARIO--(Marketwired - June 22, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) is pleased to announce that it has entered into a convertible loan agreement (the "Loan Agreement") with EMR Capital Investment (No. 5B) Pte. Ltd., an affiliate of EMR Capital Resources Fund 1, LP ("EMR"), its largest shareholder, pursuant to which EMR will lend Crystal Peak US$12,000,000 (the "Loan").

 
CORRECTION FROM SOURCE: Crystal Peak Minerals Inc. Announces Receipt of Substantial Utah Tax Credit

2017-06-05 marketwired
This document corrects and replaces the press release that was sent on May 31, 2017 at 07:30 a.m. ET.

 
BRIEF-Crystal Peak Minerals announces receipt of substantial Utah tax credit

2017-05-31 reuters
* Announced receipt of a Utah high cost infrastructure tax credit issued by Utah office of energy development

 
Crystal Peak Minerals Inc. Announces Receipt of Substantial Utah Tax Credit

2017-05-31 marketwired
TORONTO, ONTARIO--(Marketwired - May 31, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) today announced receipt of a Utah High Cost Infrastructure Tax Credit ("Infrastructure Tax Credit") issued by the Utah Office of Energy Development. The non-refundable Infrastructure Tax Credit awarded to Crystal Peak totals approximately $112,500,000 (USD).

 
Crystal Peak Minerals Inc. Announces New Board Member

2017-04-07 marketwired
TORONTO, ONTARIO--(Marketwired - April 7, 2017) - Crystal Peak Minerals Inc. ("Crystal Peak" or the "Company") (TSX VENTURE:CPM)(OTCQX:CPMMF) today announced that it appointed Aaron Hood to its Board of Directors ("Board") effective March 31, 2017. In his role as board member, he will help oversee the Company's Sevier Lake Playa Sulphate of Potash ("SOP") Project located in southwestern Utah. With this appointment, the Board increases to nine members.

 
Lithium Miner News For The Month Of February 2017

2017-02-27 seekingalpha
Lithium market news - Dr. David Deak quoted: "To electrify the world’s fleet of vehicles: mine over 3.1 million t LCE of lithium every year, for 20 years".

 
International Lithium Is Partnered To Succeed

2017-02-21 seekingalpha
ILC has a key partner - Ganfeng Lithium - a major player in the lithium world.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 22938T107